Gorman Kevin Charles
Xencor, Inc. · Director
Gorman Kevin Charles is listed in filings as Director at Xencor, Inc.. This profile follows SEC Form 4 activity through May 29, 2026, including sale activity. Recent filings connect the profile to Xencor, Inc. (XNCR) and Neurocrine Biosciences Inc (NBIX). The current snapshot covers public activity from Jun 17, 2024 to May 29, 2026. Reported amounts are shown as $255.1K to $29.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $55k2.7k shares | SellSep 27, 2024 | $20.68 | $14.98 | |
| $29k3.2k shares | SellJun 16, 2025 | $9.22 | $14.98 | |
| $1M9.6k shares | SellMay 27, 2025 | $120.38 | $174.08 | |
| $13M106.3k shares | SellAug 7, 2025 | $126.41 | $174.08 |